↓ Skip to main content

SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient with Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two…

Overview of attention for article published in Internal Medicine, March 2020
Altmetric Badge

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient with Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two Drug Classes
Published in
Internal Medicine, March 2020
DOI 10.2169/internalmedicine.4323-19
Pubmed ID
Authors

Kenta Nonomura, Katsumi Iizuka, Yayoi Kuwabara-Ohmura, Daisuke Yabe

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 24%
Student > Master 4 16%
Researcher 2 8%
Lecturer 1 4%
Student > Doctoral Student 1 4%
Other 4 16%
Unknown 7 28%
Readers by discipline Count As %
Medicine and Dentistry 9 36%
Pharmacology, Toxicology and Pharmaceutical Science 3 12%
Unspecified 1 4%
Economics, Econometrics and Finance 1 4%
Nursing and Health Professions 1 4%
Other 2 8%
Unknown 8 32%